Dr. Schrag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3601 The Vanderbilt Clinic
Neurology Suite
Nashville, TN 37232Phone+1 615-936-0060Fax+1 615-936-0605- Is this information wrong?
Summary
- I run a specialty clinic focusing on cerebral amyloid angiopathy and other microvascular diseases of the brain including CADASIL, Binswanger's disease, COL4a1-vasculopathy, infectious angiopathy and RCVS. My research laboratory focuses on understanding the neurobiology of vascular fragility in cerebral amyloid angiopathy.
Education & Training
Yale-New Haven Medical CenterResidency, Neurology, 2012 - 2015- Yale-New Haven Medical CenterInternship, Internal Medicine, 2011 - 2012
Loma Linda University School of MedicineClass of 2011
Certifications & Licensure
KY State Medical License 2017 - 2025
TN State Medical License 2015 - 2024- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Publications & Presentations
PubMed
- IV Thrombolysis for central retinal artery occlusion - Real-world experience from a comprehensive stroke center.Christoph Stretz, John E Paddock, Tina M Burton, Tatiana Bakaeva, Melissa Freeman, Aparna Choudhury, Shadi Yaghi, Karen L Furie, Matthew Schrag, Brian C MacGrory> ;Journal of Stroke and Cerebrovascular Diseases. 2024 Apr 1
- 1 citationsApixaban versus Aspirin for Embolic Stroke of Undetermined Source.Geisler, T., Keller, T., Martus, P., Poli, K., Serna-Higuita, L., Schreieck, J., Gawaz, M., Tünnerhoff, J., Bombach, P., Nägele, T., Klose, U., Aidery, P., Groga-Bada,...> ;NEJM Evidence. 2024 Jan 1
- 4 citationsFatal iatrogenic cerebral β-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer's disease.Solopova, E., Romero-Fernandez, W., Ventura-Antunes, L., Wang, E., Shostak, A., Maldonado, J., Donahue, M., Coyne, T., Charidimou, A., Harmsen, H., Schultz, D., Schrag...> ;Nature Communications. 2023 Dec 12
- Join now to see all
Journal Articles
- Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer DiseaseHyun-Sik Yang, Reisa Sperling, Matthew Schrag, Richard Mayeux, JAMA Neurology
Authored Content
- Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer DiseaseJune 2020
Press Mentions
Alzheimer’s Drugs Are Arriving, but They Won’t Be Risk FreeMay 23rd, 2023- The Brain Isn’t the Only Place Where a Stroke Can OccurMay 21st, 2023
- Why Are Makers of Alzheimer’s ‘Wonder Drug’ so Silent over Its Side Effects?May 1st, 2023
- Join now to see all
Other Languages
- Spanish
Hospital Affiliations
Vanderbilt University Medical CenterNashville, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
